Short communication

Prospective comparison of qualitative versus quantitative polymerase chain reaction for monitoring virologic treatment failure in HIV-infected patients

Su Jin Jeong, Min Hyung Kim, Je Eun Song, Jin Young Ahn, Sun Bean Kim, Hea Won Ann, Jae Kyung Kim, Heun Choi, Nam Su Ku, Sang Hoon Han, June Myung Kim, Davey M. Smith, Hyonsuk Kim, JunYong Choi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Less costly but still accurate methods for monitoring HIV treatment response are needed. We prospectively evaluated if a qualitative polymerase chain reaction (PCR) amplification assay for virologic monitoring could maintain accuracy while reducing costs in Seoul, South Korea. We conducted the first prospective study comparing a qualitative PCR amplification of HIV-1 reverse transcriptase (RT) versus a commercial real time PCR assay (i.e., viral load) for virologic monitoring of 150 patients receiving antiretroviral therapy (ART) between November 2011 and August 2012 at an urban hospital in Seoul, South Korea. A total of 215 blood plasma samples from 150 patients receiving ART for more than 6 months were evaluated. Using the individual viral load assay, 12 of 215 (5.6%) plasma samples had more than 500 HIV RNA copies/ml. The qualitative PCR amplification assay detected individual samples with ≥500 HIV RNA copies/ml with 100% sensitivity. The specificities of the qualitative PCR amplification of the HIV-1 RT assay were 94.1%, 93.6%, and 93.2% compared to the real time PCR at 500, 1,000, and 5,000 threshold of HIV RNA copies/ml, respectively, and $24,940 USD would have been saved for 150 patients during 10 months. The qualitative PCR amplification of the HIV-1 RT assay might be a useful approach to effectively monitor patients receiving ART and save resources.

Original languageEnglish
Pages (from-to)827-829
Number of pages3
JournalAIDS Research and Human Retroviruses
Volume30
Issue number8
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Treatment Failure
Communication
HIV
Polymerase Chain Reaction
Republic of Korea
RNA
Viral Load
Real-Time Polymerase Chain Reaction
Urban Hospitals
Physiologic Monitoring
Therapeutics
Prospective Studies
Costs and Cost Analysis
Human immunodeficiency virus 1 reverse transcriptase
Seoul

All Science Journal Classification (ASJC) codes

  • Immunology
  • Virology
  • Infectious Diseases

Cite this

Jeong, Su Jin ; Kim, Min Hyung ; Song, Je Eun ; Ahn, Jin Young ; Kim, Sun Bean ; Ann, Hea Won ; Kim, Jae Kyung ; Choi, Heun ; Ku, Nam Su ; Han, Sang Hoon ; Kim, June Myung ; Smith, Davey M. ; Kim, Hyonsuk ; Choi, JunYong. / Short communication : Prospective comparison of qualitative versus quantitative polymerase chain reaction for monitoring virologic treatment failure in HIV-infected patients. In: AIDS Research and Human Retroviruses. 2014 ; Vol. 30, No. 8. pp. 827-829.
@article{7caeba4b27f3497d9353e03725a8fcbd,
title = "Short communication: Prospective comparison of qualitative versus quantitative polymerase chain reaction for monitoring virologic treatment failure in HIV-infected patients",
abstract = "Less costly but still accurate methods for monitoring HIV treatment response are needed. We prospectively evaluated if a qualitative polymerase chain reaction (PCR) amplification assay for virologic monitoring could maintain accuracy while reducing costs in Seoul, South Korea. We conducted the first prospective study comparing a qualitative PCR amplification of HIV-1 reverse transcriptase (RT) versus a commercial real time PCR assay (i.e., viral load) for virologic monitoring of 150 patients receiving antiretroviral therapy (ART) between November 2011 and August 2012 at an urban hospital in Seoul, South Korea. A total of 215 blood plasma samples from 150 patients receiving ART for more than 6 months were evaluated. Using the individual viral load assay, 12 of 215 (5.6{\%}) plasma samples had more than 500 HIV RNA copies/ml. The qualitative PCR amplification assay detected individual samples with ≥500 HIV RNA copies/ml with 100{\%} sensitivity. The specificities of the qualitative PCR amplification of the HIV-1 RT assay were 94.1{\%}, 93.6{\%}, and 93.2{\%} compared to the real time PCR at 500, 1,000, and 5,000 threshold of HIV RNA copies/ml, respectively, and $24,940 USD would have been saved for 150 patients during 10 months. The qualitative PCR amplification of the HIV-1 RT assay might be a useful approach to effectively monitor patients receiving ART and save resources.",
author = "Jeong, {Su Jin} and Kim, {Min Hyung} and Song, {Je Eun} and Ahn, {Jin Young} and Kim, {Sun Bean} and Ann, {Hea Won} and Kim, {Jae Kyung} and Heun Choi and Ku, {Nam Su} and Han, {Sang Hoon} and Kim, {June Myung} and Smith, {Davey M.} and Hyonsuk Kim and JunYong Choi",
year = "2014",
month = "1",
day = "1",
doi = "10.1089/aid.2013.0227",
language = "English",
volume = "30",
pages = "827--829",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "8",

}

Short communication : Prospective comparison of qualitative versus quantitative polymerase chain reaction for monitoring virologic treatment failure in HIV-infected patients. / Jeong, Su Jin; Kim, Min Hyung; Song, Je Eun; Ahn, Jin Young; Kim, Sun Bean; Ann, Hea Won; Kim, Jae Kyung; Choi, Heun; Ku, Nam Su; Han, Sang Hoon; Kim, June Myung; Smith, Davey M.; Kim, Hyonsuk; Choi, JunYong.

In: AIDS Research and Human Retroviruses, Vol. 30, No. 8, 01.01.2014, p. 827-829.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Short communication

T2 - Prospective comparison of qualitative versus quantitative polymerase chain reaction for monitoring virologic treatment failure in HIV-infected patients

AU - Jeong, Su Jin

AU - Kim, Min Hyung

AU - Song, Je Eun

AU - Ahn, Jin Young

AU - Kim, Sun Bean

AU - Ann, Hea Won

AU - Kim, Jae Kyung

AU - Choi, Heun

AU - Ku, Nam Su

AU - Han, Sang Hoon

AU - Kim, June Myung

AU - Smith, Davey M.

AU - Kim, Hyonsuk

AU - Choi, JunYong

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Less costly but still accurate methods for monitoring HIV treatment response are needed. We prospectively evaluated if a qualitative polymerase chain reaction (PCR) amplification assay for virologic monitoring could maintain accuracy while reducing costs in Seoul, South Korea. We conducted the first prospective study comparing a qualitative PCR amplification of HIV-1 reverse transcriptase (RT) versus a commercial real time PCR assay (i.e., viral load) for virologic monitoring of 150 patients receiving antiretroviral therapy (ART) between November 2011 and August 2012 at an urban hospital in Seoul, South Korea. A total of 215 blood plasma samples from 150 patients receiving ART for more than 6 months were evaluated. Using the individual viral load assay, 12 of 215 (5.6%) plasma samples had more than 500 HIV RNA copies/ml. The qualitative PCR amplification assay detected individual samples with ≥500 HIV RNA copies/ml with 100% sensitivity. The specificities of the qualitative PCR amplification of the HIV-1 RT assay were 94.1%, 93.6%, and 93.2% compared to the real time PCR at 500, 1,000, and 5,000 threshold of HIV RNA copies/ml, respectively, and $24,940 USD would have been saved for 150 patients during 10 months. The qualitative PCR amplification of the HIV-1 RT assay might be a useful approach to effectively monitor patients receiving ART and save resources.

AB - Less costly but still accurate methods for monitoring HIV treatment response are needed. We prospectively evaluated if a qualitative polymerase chain reaction (PCR) amplification assay for virologic monitoring could maintain accuracy while reducing costs in Seoul, South Korea. We conducted the first prospective study comparing a qualitative PCR amplification of HIV-1 reverse transcriptase (RT) versus a commercial real time PCR assay (i.e., viral load) for virologic monitoring of 150 patients receiving antiretroviral therapy (ART) between November 2011 and August 2012 at an urban hospital in Seoul, South Korea. A total of 215 blood plasma samples from 150 patients receiving ART for more than 6 months were evaluated. Using the individual viral load assay, 12 of 215 (5.6%) plasma samples had more than 500 HIV RNA copies/ml. The qualitative PCR amplification assay detected individual samples with ≥500 HIV RNA copies/ml with 100% sensitivity. The specificities of the qualitative PCR amplification of the HIV-1 RT assay were 94.1%, 93.6%, and 93.2% compared to the real time PCR at 500, 1,000, and 5,000 threshold of HIV RNA copies/ml, respectively, and $24,940 USD would have been saved for 150 patients during 10 months. The qualitative PCR amplification of the HIV-1 RT assay might be a useful approach to effectively monitor patients receiving ART and save resources.

UR - http://www.scopus.com/inward/record.url?scp=84905499455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905499455&partnerID=8YFLogxK

U2 - 10.1089/aid.2013.0227

DO - 10.1089/aid.2013.0227

M3 - Article

VL - 30

SP - 827

EP - 829

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 8

ER -